Bachem has shocked the pharmaceutical industry with its massive $2.3 billion acquisition of AmWiner, marking one of the largest deals in the peptide therapeutics sector this year. This strategic takeover signals Bachem's ambitious wholesale peptide supplier plans to dominate the growing market for p